{"id":15102,"date":"2020-09-25T16:30:07","date_gmt":"2020-09-25T20:30:07","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=15102"},"modified":"2020-09-25T17:03:33","modified_gmt":"2020-09-25T21:03:33","slug":"09-21-20-09-25-20-ipo-summary","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/09-21-20-09-25-20-ipo-summary\/","title":{"rendered":"IPO WEEKLY RECAP: Winners Galore as IPO Boom Continues!"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">It was another extremely <\/span><b>active week<\/b><span style=\"font-weight: 400;\"> on the syndicate market as nine deals came to market with mostly success.<\/span><!--more--><br \/>\n<a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Capture-1.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone wp-image-15103 size-full\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Capture-1.jpg\" alt=\"\" width=\"1655\" height=\"299\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Capture-1.jpg 1655w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Capture-1-600x108.jpg 600w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Capture-1-300x54.jpg 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Capture-1-1024x185.jpg 1024w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Capture-1-768x139.jpg 768w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Capture-1-1536x278.jpg 1536w\" sizes=\"(max-width: 1655px) 100vw, 1655px\" \/><\/a><\/p>\n<p><span style=\"font-weight: 400;\">\u00a0Healthcare and biotech was in the \u201cspotlight\u201d and deals in these sectors did not disappoint.\u00a0<\/span><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/GoodRx.png\"><img decoding=\"async\" class=\"alignnone size-medium wp-image-14926\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/GoodRx-300x104.png\" alt=\"\" width=\"300\" height=\"104\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/GoodRx-300x104.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/GoodRx.png 573w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Capture-1.jpg\"><br \/>\n<\/a><\/p>\n<p><b>GoodRx Holdings, Inc. (GDRX)<\/b><span style=\"font-weight: 400;\"> priced a full-size deal, <\/span><b>34.6mm shares, at $33.00<\/b><span style=\"font-weight: 400;\"> ($5.00 above the range) and <\/span><b>opened at $46.00 for a gain of 39.4% at first trade. GDRX <\/b><span style=\"font-weight: 400;\">traded to a first day high of $51.78 and hung \u201cclose to 50\u201d most of its opening week.\u00a0<\/span><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Screen-Shot-2020-09-21-at-10.26.55-AM.png\"><img decoding=\"async\" class=\"alignnone size-medium wp-image-14943\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Screen-Shot-2020-09-21-at-10.26.55-AM-300x61.png\" alt=\"\" width=\"300\" height=\"61\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Screen-Shot-2020-09-21-at-10.26.55-AM-300x61.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Screen-Shot-2020-09-21-at-10.26.55-AM.png 437w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p><b>PMV Pharmaceuticals, Inc (PMVP) <\/b><span style=\"font-weight: 400;\">priced <\/span><b>11.765mm shares at $18.00<\/b><span style=\"font-weight: 400;\"> (high-end of the range) and<\/span><b> opened at $35.00 for a gain of 94.4% at first trade.<\/b><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Prelude.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-14953\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Prelude.png\" alt=\"\" width=\"287\" height=\"118\" \/><\/a><\/p>\n<p><b>Prelude Therapeutics Incorporated (P<\/b><span style=\"font-weight: 400;\"><strong>RLD)<\/strong> priced a full-size deal, 8.325mm shares, at the high-end of the range, $19.00, <\/span><b>and opened at $25.23 for a gain of 32.8% at first trade.\u00a0<\/b><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Taysha.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-14938\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Taysha-300x85.png\" alt=\"\" width=\"300\" height=\"85\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Taysha-300x85.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Taysha.png 479w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p><b>Taysha Gene Therapies, Inc. (TS<\/b><span style=\"font-weight: 400;\">HA) priced 7.9mm shares (upsized from 6.6mm) at $20.00 (high-end of range<\/span><b>) and opened at $22.25 for a gain of 11.3% at first trade. TSHA<\/b><span style=\"font-weight: 400;\"> traded well in its first two sessions and hit a high of $27.53 for a gain of 38% at its highest print.<\/span><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/graybug.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-14947\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/graybug-300x74.png\" alt=\"\" width=\"300\" height=\"74\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/graybug-300x74.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/graybug.png 452w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p><b>Graybug Vision, Inc. (GRAY)<\/b><span style=\"font-weight: 400;\"> priced <\/span><b>5.625mm shares<\/b><span style=\"font-weight: 400;\"> (upsized from 4.7mm) <\/span><b>at $16.00<\/b><span style=\"font-weight: 400;\"> (midpoint of the range) and <\/span><b>opened at $19.00 for a gain of 18.8% at first trade.\u00a0<\/b><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Screen-Shot-2020-09-21-at-9.58.41-AM.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-14920\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Screen-Shot-2020-09-21-at-9.58.41-AM.png\" alt=\"\" width=\"267\" height=\"66\" \/><\/a><\/p>\n<p><b>Bentley Systems Inc (BSY)<\/b><span style=\"font-weight: 400;\"> priced a full-size deal, 10.75mm shares, at $22.00 ($1.00 above the upwardly-revised range)<\/span><b> and opened at $28.00 for a gain of 27.3% at first trade. BSY<\/b><span style=\"font-weight: 400;\"> had buyers throughout its opening week as the stock closed its first session (Wednesday) at $33.49 and held north of 30 in both the Thursday and Friday sessions.\u00a0<\/span><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Laird.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-14934\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Laird-300x160.png\" alt=\"\" width=\"300\" height=\"160\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Laird-300x160.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Laird.png 599w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p><b>\u00a0Laird Superfood, Inc. (LSF) <\/b><span style=\"font-weight: 400;\">priced <\/span><b>2.65mm shares at $22.00<\/b><span style=\"font-weight: 400;\"> (high-end of upwardly-revised range) and <\/span><b>opened at $33.55 for a gain of 52.5% at first trade. LSF\u00a0<\/b>traded extremely strong and <strong>closed the week at an even $45.00<\/strong> for more than a 100% gain as a publicly traded company.<\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Corsair.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-14922\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Corsair.png\" alt=\"\" width=\"260\" height=\"190\" \/><\/a><\/p>\n<p><b>Corsair Gaming, Inc. (CRSR) <\/b><span style=\"font-weight: 400;\">priced a full-size deal, <\/span><b>14.0mm shares<\/b><span style=\"font-weight: 400;\">, at the midpoint of the range,<\/span><b> $17.00<\/b><span style=\"font-weight: 400;\">, and <\/span><b>opened at $15.12 for a loss of 11.1% at first trade. CRSR <\/b><span style=\"font-weight: 400;\">caught a bid on its third trading day, Friday, and rallied through the IPO price and north of $18.\u00a0\u00a0<\/span><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/VIAO.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-14959\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/VIAO-300x68.png\" alt=\"\" width=\"300\" height=\"68\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/VIAO-300x68.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/VIAO.png 387w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p><b>VIA optronics AG (VIAO)<\/b><span style=\"font-weight: 400;\"> priced a full-size deal, <\/span><b>6.25mm ADSs<\/b><span style=\"font-weight: 400;\">, at the low-end of the range, <\/span><b>$15.00<\/b><span style=\"font-weight: 400;\">, and opened at <\/span><b>$12.00 <\/b><span style=\"font-weight: 400;\">for a loss of 20% at first trade.<\/span><span style=\"font-weight: 400;\"> This offering was backed by a German underwriter, Berenberg.<\/span><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Capture-1.jpg\"><br \/>\n<\/a><\/p>\n<p><span style=\"font-weight: 400;\">Two IPOs that were anticipated to come to market this week did not for differing reasons. .\u00a0<\/span><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Capture-1.jpg\"><br \/>\n<\/a><\/p>\n<p><b>Orphazyme A\/S (ORPH)<\/b><span style=\"font-weight: 400;\">, which has its stock also trade on the Nasdaq Copenhage, <\/span><b>released positive news<\/b><span style=\"font-weight: 400;\"> about its product candidate Friday morning and is now tracking a Monday pricing for a Tuesday (9\/29) trade date.<\/span><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Capture-1.jpg\"><br \/>\n<\/a><\/p>\n<p><b>Hygo Energy Transition Ltd. (HYGO)<\/b><span style=\"font-weight: 400;\"> &#8212; According to underwriter guidance, this offering has been <\/span><b>postponed<\/b><span style=\"font-weight: 400;\">. There is no further information at this time.\u00a0<\/span><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2020\/09\/Capture-1.jpg\"><br \/>\n<\/a><\/p>\n<p><span style=\"font-weight: 400;\">Looking ahead to this week, there are eight IPOs on the schedule:<\/span><\/p>\n<p><span style=\"text-decoration: underline;\"><strong>Debuting Tuesday (9\/29)<\/strong><\/span><\/p>\n<p><b>Boqii Holding Limited (BQ)<span style=\"font-weight: 400;\"> &#8212; <\/span><\/b>They are the largest pet-focused platform in China, in terms of revenue in 2019 and number of customers as of December 31, 2019, according to Frost &amp; Sullivan.<\/p>\n<p><b>Orphazyme A\/S (ORPH) &#8212; <\/b>They are a late-stage biopharmaceutical company harnessing the amplification of Heat Shock Proteins, or HSPs, in order to develop and commercialize novel therapeutics for the treatment of neurodegenerative orphan diseases.<\/p>\n<p><span style=\"text-decoration: underline;\"><strong>Debuting Wednesday (9\/30)<\/strong><\/span><\/p>\n<p><b>Chindata Group Holdings Limited (CD)<\/b><b> &#8212; <\/b><span style=\"font-weight: 400;\">\u00a0<\/span>They are the leading carrier-neutral hyperscale data center solution provider in Asia-Pacific emerging markets, focusing on the China, India and Southeast Asia markets<span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><b>Lixiang Education Holding Co., Ltd. (LXEH)<\/b><span style=\"font-weight: 400;\"> &#8212; <\/span>They are a prominent private primary and secondary education service provider in Lishui City, Zhejiang Province.<\/p>\n<p><b>Yalla Group Limited (YALA)<\/b><span style=\"font-weight: 400;\"> &#8212; <\/span>They are the largest voice-centric social networking and entertainment platform in MENA (Middle East &amp; North Africa) as measured by revenue in 2019, according to the Frost &amp; Sullivan Report.<\/p>\n<p><span style=\"text-decoration: underline;\"><strong>Debuting Thursday (10\/1)<\/strong><\/span><\/p>\n<p><b>Mission Produce, Inc. (AVO)<\/b><span style=\"font-weight: 400;\"> &#8212;<\/span> They are a world leader in sourcing, producing and distributing fresh avocados, serving retail, wholesale and foodservice customers in over 25 countries. <span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><b>Pulmonx Corporation\u00a0 (LUNG)<\/b><span style=\"font-weight: 400;\"> &#8212; <\/span>They are a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD).<\/p>\n<p><span style=\"text-decoration: underline;\"><strong>Debuting Friday (10\/2)<\/strong><\/span><\/p>\n<p><b>Academy Sports and Outdoors, Inc. (ASO)<\/b><span style=\"font-weight: 400;\"> &#8212; <\/span>They are one of the leading full-line sporting goods and outdoor recreation retailers in the United States.<\/p>\n<p><b>Immunome Inc. (INMN)<\/b><span style=\"font-weight: 400;\"> &#8212; <\/span>They are a biopharmaceutical company utilizing their proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated.<\/p>\n<hr \/>\n<hr \/>\n<p><span style=\"font-weight: 400;\">In addition, there are two companies debuting via a <\/span><b>direct listing. Palantir Technologies (PLTR) &amp; Asana Inc (ASAN) <\/b><span style=\"font-weight: 400;\">are both tentatively scheduled to debut on 9\/30. Because these companies are going public through the direct listing route, <\/span><b>we will not be providing coverage on their company leading up to the debut<\/b><span style=\"font-weight: 400;\">.\u00a0\u00a0<\/span><\/p>\n<p>For IPO Boutique Research, Ratings and Commentary on all traditional IPO offerings (not direct listings), try us out:<strong><a href=\"http:\/\/www.ipoboutique.com\/blog\/register\/\"> http:\/\/www.ipoboutique.com\/blog\/register\/<\/a><\/strong><\/p>\n<p><em>IPO Boutique: Indicate with Confidence.<\/em><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>It was another extremely active week on the syndicate market as nine deals came to market with mostly success.<\/p>\n","protected":false},"author":5,"featured_media":14912,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,2058,1536],"tags":[2218,2219,2220,2221,2222,2223,2224,2225,2226,2227,2228],"class_list":["post-15102","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","category-spotlight","category-subscriber-content","tag-bsy","tag-crsr","tag-gdrx","tag-gray","tag-hygo","tag-lsf","tag-orph","tag-pmvp","tag-prld","tag-tsha","tag-viao"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/15102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=15102"}],"version-history":[{"count":5,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/15102\/revisions"}],"predecessor-version":[{"id":15108,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/15102\/revisions\/15108"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media\/14912"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=15102"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=15102"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=15102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}